Literature DB >> 1500747

Role of cell wall polysaccharide in the assessment of IgG antibodies to the capsular polysaccharides of Streptococcus pneumoniae in childhood.

D Goldblatt1, R J Levinsky, M W Turner.   

Abstract

The interference of antibodies to pneumococcal cell wall polysaccharide (CWPS) in the measurement of antibodies to capsular polysaccharides in children was assessed after vaccination with pneumococcal polysaccharide vaccine. ELISAs were developed to measure IgG subclasses specific for pneumococcal types 3, 6, 19, and 23 and CWPS. Analysis of antibody levels to all four capsular polysaccharides was affected by the presence of antibodies to CWPS, and their removal altered both anti-capsular polysaccharide antibody levels and the interpretation of responses to the vaccine. Thus, it is likely that CWPS contaminating pure capsular polysaccharide reagents used in most standard immunoassays is responsible for falsely elevated measurements of antibodies to capsular polysaccharide and the incorrect assessment of anti-pneumococcal antibody status in childhood.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1500747     DOI: 10.1093/infdis/166.3.632

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  5 in total

1.  Clinical and immunological evaluation of patients with mild IgG1 deficiency.

Authors:  D A Van Kessel; P E Horikx; A J Van Houte; C S De Graaff; H Van Velzen-Blad; G T Rijkers
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

2.  Pneumococcal conjugate vaccines overcome splenic dependency of antibody response to pneumococcal polysaccharides.

Authors:  M A Breukels; A Zandvoort; G P van Den Dobbelsteen; A van Den Muijsenberg; M E Lodewijk; M Beurret; P A Klok; W Timens; G T Rijkers
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

3.  Immunoglobulin G antibody responses to polyvalent pneumococcal vaccine in children in the highlands of Papua New Guinea.

Authors:  W S Pomat; D Lehmann; R C Sanders; D J Lewis; J Wilson; S Rogers; T Dyke; M P Alpers
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

4.  Peptide mimicry of the meningococcal group C capsular polysaccharide.

Authors:  M A Westerink; P C Giardina; M A Apicella; T Kieber-Emmons
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

5.  Antibody and plasmablast response to 13-valent pneumococcal conjugate vaccine in chronic lymphocytic leukemia patients--preliminary report.

Authors:  Marcin Pasiarski; Jacek Rolinski; Ewelina Grywalska; Agnieszka Stelmach-Goldys; Izabela Korona-Glowniak; Stanislaw Gozdz; Iwona Hus; Anna Malm
Journal:  PLoS One       Date:  2014-12-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.